UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-QSB



[ X ]
        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OFTHE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended:
        September 30, 2007




OR



o
        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OFTHE SECURITIES EXCHANGE ACT OF 1934




For the transition period from
        
        toCommission file number:
        000-51603






American CareSource Holdings, Inc.

(Exact name of small business issuer as specified in its charter)



Delaware
        
        20-0428568(State or other jurisdiction of
        
        (I.R.S. Employer Identification No.)incorporation or organization)




5429 Lyndon B. Johnson Freeway, Suite 700, Dallas, Texas

(Address of principal executive offices)



(972) 308-6830

(Issuers telephone number, including area code)

_______________________________________________________________

(Former name, former address, and former fiscal year, if changed since last report)



Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 (the Exchange Act) during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.

Yesx
        Noo




Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   YesoNox



State the number of shares outstanding of each of the issuers classes of common equity, as of the latest practicable date: As of November 12, 2007, 14,661,758 shares of the Companys common stock, par value $0.01 per share, were outstanding.



Transitional Small Business Disclosure Format (check one)
        Yeso
        Nox






---





TABLE OF CONTENTS



AMERICAN CARESOURCE HOLDINGS, INC.



FORM 10-QSB QUARTER ENDED SEPTEMBER 30, 2007



Part I
        Financial Information
        3Item 1.
        Financial Statements
        3Unaudited Consolidated Balance Sheets
        3Unaudited Consolidated Statements of Operations
        4Unaudited Consolidated Statement of Stockholders Equity
        6Unaudited Consolidated Statements of Cash Flows
        7Notes to Unaudited Consolidated Financial Statements
        8Item 2.
        Managements Discussion and Analysis of Financial Condition and Results of Operation
        13Risk Factors
        20Item 3.
        Controls and Procedures
        22Part II
        Other Information
        23Item 1.
        Legal Proceedings
        23Item 5.
        Other Information
        23Item 6.
        Exhibits
        23Signatures
        
        24






2



---



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements



AMERICAN CARESOURCE HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (UNAUDITED)



As ofASSETS
        September 30, 2007
        
        December 31, 2006CURRENT ASSETSCash
        $3,630,133
        
        $5,025,380Accounts Receivable
        2,467,471
        
        1,334,950Other
        614,869
        
        33,515Total Current Assets
        6,712,473
        
        6,393,845Net Property, Plant, and Equipment
        318,144
        
        266,555Other AssetsCertificate of Deposit, Restricted
        145,000
        
        145,000Intangible Assets
        1,547,633
        
        1,707,819Goodwill
        4,361,299
        
        4,361,299Total Other Assets
        6,053,932
        
        6,214,118Total Assets
        $13,084,549
        
        $12,874,518Liabilities and Stockholders' EquityCurrent LiabilitiesDue to Service Providers
        $1,881,702
        
        $1,077,174Accounts Payable and Accrued Liabilities
        1,174,304
        
        761,926Current Maturities of Long-Term Debt
        55,041
        
        352,718Total Current Liabilities
        3,111,047
        
        2,191,818Long-Term Debt
        59,910
        
        101,541Total Liabilities
        3,170,957
        
        2,293,359stockholders' Equity:Common Stock-par value $0.01, 40,000,000 shares authorized and 14,654,167 and 14,486,615 shares issued and outstanding as of September 30, 2007 and December 31, 2006 respectively
        146,542
        
        144,866Preferred Stock-par value $0.01, 10,000,000 shares authorized and none outstanding
        -
        
        -Additional Paid in Capital
        17,457,604
        
        17,034,176Deferred Debt Issuance Cost
        -
        
        (46,300)Accumulated (Deficit)
        (7,690,554)
        
        (6,551,583)Total Stockholders Equity
        9,913,592
        
        10,581,159Total Liabilities and Equity
        $13,084,549
        
        $12,874,518




See notes to unaudited consolidated financial statements.



3



---



AMERICAN CARESOURCE HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)



Three Months EndedSeptember 30,2007
        2006REVENUESNet Ancillary Health
        $7,088,499
        $3,283,570Patient Claims Processing
        -
        29,870Net Revenue
        7,088,499
        3,313,440Total Cost of Revenues
        6,091,789
        2,689,471Net Margin
        996,710
        623,969Selling, General, and Administrative Expense
        766,648
        665,841Depreciation and Amortization
        86,445
        77,271Total Operating Expense
        853,093
        743,112Operating  Income (Loss)
        143,617
        (119,143)Net Interest (Income)
        (47,430)
        (57,241)Interest Expense
        2,836
        8,174Debt Issuance Cost
        -
        46,300Total Other (Income) Expense
        (44,594)
        (2,767)Net Income (Loss) Before Income Tax
        188,211
        (116,376)Income Tax Expense
        -
        -Net Income (Loss)
        $188,211
        $(116,376)NET INCOME (LOSS) PER SHARE  BASIC
        $0.01
        $(0.01)WEIGHTED AVERAGE COMMON SHARES  BASIC
        14,555,314
        14,472,867NET INCOME (LOSS) PER SHARE  DILUTED
        $0.01
        $(0.01)WEIGHTED AVERAGE COMMON SHARES  DILUTED
        16,888,882
        14,472,867




See notes to unaudited consolidated financial statements.



4



---



AMERICAN CARESOURCE HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)



Nine Months EndedSeptember 30,2007
        2006REVENUESNet Ancillary Health
        $13,363,356
        $8,512,425Patient Claims Processing
        -
        95,337Net Revenue
        13,363,356
        8,607,762Total Cost of Revenues
        11,671,724
        6,904,779Net Margin
        1,691,632
        1,702,983Selling, General, and Administrative Expense
        2,677,920
        2,038,718Depreciation and Amortization
        248,160
        235,618Total Operating Expense
        2,926,080
        2,274,336Operating (Loss)
        (1,234,448)
        (571,353)Net Interest (Income)
        (151,063)
        (132,753)Interest Expense
        9,286
        63,082Debt Issuance Cost
        46,300
        138,900Total Other (Income) Expense
        (95,477)
        69,229Net Income (Loss) Before Income Tax
        (1,138,971)
        (640,582)Income Tax Expense
        -
        -Net Income (Loss)
        $(1,138,971)
        $(640,582)NET INCOME (LOSS) PER SHARE  BASIC
        $(0.08)
        $(0.05)WEIGHTED AVERAGE COMMON SHARES  BASIC
        14,511,642
        14,066,192NET INCOME (LOSS) PER SHARE  DILUTED
        $(0.08)
        $(0.05)WEIGHTED AVERAGE COMMON SHARES  DILUTED
        14,511,642
        14,066,192




See notes to unaudited consolidated financial statements.



5



---





AMERICAN CARESOURCE HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE NINE MONTHS ENDED September 30, 2007 (UNAUDITED)Common Stock
        
        Deferred
        AccumShares
        Amount
        APIC
        Debt
        Deficit
        TotalBalance December 31, 2006
        14,486,615
        $ 144,866
        $17,034,176
        $(46,300)
        $(6,551,583)
        $ 10,581,159Issuance of Common Stock Warrants
        -
        -
        52,913
        -
        -
        52,913Exercise of 167,552 Stock Options
        167,552
        1,676
        50,550
        -
        -
        52,226Option Compensation Expense
        -
        -
        319,965
        -
        -
        319,965Amortization of Warrants
Associated with Deferred Debt
        -
        -
        -
        46,300
        -
        46,300Net Loss
        -
        -
        -
        -
        (1,138,971)
        (1,138,971)Balance
September 30, 2007
        14,654,167
        $146,542
        $17,457,604
        $              -
        $(7,690,554)
        $9,913,592






6



---



AMERICAN CARESOURCE HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)



Nine Months EndedSeptember 30,2007
        2006OPERATING ACTIVITIES:Net loss
        $(1,138,971)
        $(640,582)Adjustments to reconcile net loss to net cash used in operating activities:Stock option compensation expense
        319,965
        137,615Depreciation and amortization
        248,160
        235,618Compensation expense related to warrants
        46,300
        138,900Client management fee expense related to warrants
        22,047
        -(Gain) on disposal of assets
        -
        (33,359)Changes in operating assets and liabilities:(Increase) decrease in accounts receivable
        (1,132,521)
        (1,514,904)(Increase) in other current assets
        (550,488)
        (107,524)Increase  in accounts payable and accrued liabilities
        412,378
        299,173Increase (decrease) in amounts payable to service providers
        804,528
        1,060,363Net cash (used in) operating activities
        (968,602)
        (424,700)INVESTING ACTIVITIES:Purchase of property and equipment
        (139,563)
        (161,866)Sales of equipment
        -
        65,225Net cash (used in) investing activities
        (139,563)
        (96,641)FINANCING ACTIVITIES:Borrowings from line of credit
        -
        200,000Net proceeds from new debt
        -
        135,000Payment on line of credit or long term debt
        (339,308)
        (3,714,121)Net proceeds from the exercising of stock options
        52,226
        34,575Net proceeds from the sale of capital stock
        -
        9,069,848Net cash provided by (used in) financing activities
        $(287,082)
        $5,725,302NET INCREASE (DECREASE) IN CASH AND CASH  EQUIVALENTS
        $(1,395,247)
        $5,203,961CASH AND CASH EQUIVALENTS AT  BEGINNING OF PERIOD
        5,025,380
        23,399CASH AND CASH EQUIVALENTS AT  END OF PERIOD
        $3,630,133
        $5,227,360Supplemental disclosures cash flow informationCash paid for interest
        $28,147
        $48,591Supplemental disclosure of non-cash financing activityIssuance of warrants in payment of client management fees
        $52,913
        -




See notes to unaudited consolidated financial statements.



7



---



AMERICAN CARESOURCE HOLDINGS, INC. AND SUBSIDIARIES

Notes to Unaudited Consolidated Financial Statements for the period ended September 30, 2007

Note 1. Summary of Significant Accounting Policies

Description of business: American CareSource Holdings, Inc., a Delaware corporation (the Company, American CareSource Holdings, ACS, we, our, us, or the Registrant), and its subsidiaries are in the business of delivering ancillary healthcare services through its national network of ancillary care providers. The Company markets its products to insurance companies, third party administrators and preferred provider organizations.  American CareSource Holdings has one wholly owned subsidiary, Ancillary Care Services, Inc. (Care Services).

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the interim reporting requirements of Form 10-QSB and Item 310(b) of Regulation S-B. Consequently, financial information and disclosures normally included in financial statements prepared annually in accordance with Generally Accepted Accounting Principals (GAAP) have been condensed or omitted. Readers of this report should, therefore, refer to the consolidated financial statements and the notes included in our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006, first filed with the Securities and Exchange Commission (the SEC) on April 2, 2007 and subsequently amended and filed with the SEC on April 3, 2007.

In the opinion of management, all adjustments (consisting of normal recurring adjustments) which are necessary to fairly present our financial position and our results of operations as of and for these periods have been made.

Our interim results of operations are not necessarily indicative of results of operations that will be realized for the full fiscal year.

Use of estimates in the preparation of financial statements: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from those estimates.

Revenue recognition: The Company evaluates its service provider contracts using the indicators of EITF No. 99-19 Reporting Gross Revenue as a Principal vs. Net as an Agent (EITF 99-19) to determine whether the Company is acting as a principal or an agent in the fulfillment of services to be rendered.



Revenues are recorded gross when services by providers have been authorized and performed and collections from third party payors are reasonably assured. The Company acts as principal under EITF 99-19 when settling claims for service providers through their contracted service provider network for the following reasons:



The Company negotiates a contract with the service provider and also negotiates contracts with payors. Neither the service provider nor the payor can look through the Company and claim directly against the other party. Both contracts with these parties are separate and each only enters into contracts with the Company. Each party deals directly with the Company and does not deal with each other directly.



The Company determines through negotiations which payor will be included or excluded in the network to be offered to the service provider, based on, among other things, price and access.



The Company does not earn a fixed dollar amount per customer transaction regardless of the amount billed to customers or earn a stated percentage of the amount billed to its customers.



The Company is responsible to the service provider for processing claims and managing the claims its adjustors process.



8



---



The Company sets prices to be settled with payors and separately negotiates the prices to be settled with the service providers.



The Company may realize a positive or negative margin represented by the difference between the negotiated fees received from payors and the negotiated amount paid to service providers.



When claims are recorded gross, the payors payment to the Company is recorded as revenue and the Companys payment to the service provider is recorded as cost of revenue in the statement of operations. The Company does, however, record revenue on a net basis when an agency relationship exists. When the Company receives a fee for claims processing and there are no financial risks to the Company, then only the claims processing fee is recorded as revenue.



The Company does not have responsibility for collecting co-payments to be made or co-insurance claims to be received. Accordingly, co-payments or co-insurance claims collected are not recorded as either revenue or cost of sales.



The Company records an allowance on all sales reported as gross to arrive at a net revenue number. Co-payments, deductibles and co-insurance can all affect the collectability of individual claims. While the Company is able to re-price a claim and accurately estimate what should be paid for the particular service, the presence of co-pays, deductibles and co-insurance can all affect the ultimate collectability of a claim. In addition, the Companys collection experience with each payor varies. In 2006, the Company began recording an allowance against gross revenue to better estimate collectability. This allowance is applied specifically for each payor and is adjusted to reflect the Companys collection experience each quarter.

Accounts receivable: Accounts receivable are reported at amounts expected to be received from third party payors and other customers. Each period, the Company estimates revenue based on claims processed and actual billed revenue.  The Company recognizes a reserve each month to adjust billed revenue for co-pays and deductibles the Company will not be paid.  In addition, the reserve includes an adjustment in claims billed that will not be paid by the insurer for a variety of other potential issues. This reserve offsets accounts receivables accordingly.

The Company expects to collect the majority of its receivable amounts. Each quarter the Company reviews collections history and adjusts its revenue estimate accordingly.

Concentration of revenues: The Company has five customers that comprise the following approximate amounts of the Companys revenue and accounts receivable:



Nine Months Ended September 30, 2007
        Nine Months Ended September 30, 2006Accounts
Receivable
        Revenue
        % of Total
Revenue
        
        Accounts
Receivable
        Revenue
        % of Total
RevenueCustomer A
        $1,056,000
        $7,891,000
        59%
        
        $1,306,000
        $5,477,000
        64%Customer B
        1,261,000
        3,700,000
        28%
        
        -
        -
        0%Customer C
        191,000
        607,000
        4%
        
        -
        -
        0%Customer D
        115,000
        517,000
        4%
        
        331,000
        2,035,000
        24%Customer E
        6,000
        291,000
        2%
        
        28,000
        95,000
        1%$2,629,000
        $13,006,000
        97%
        
        $1,665,000
        $7,607,000
        89%






9



---



Stock-Based Compensation:  The Company has a stock based compensation plan, which is described more fully in Note 3 hereof and in Note 6 to the financial statements presented in our 10-KSB for the year ended December 31, 2006, filed with the SEC on April 2, 2007 and subsequently amended and filed with the SEC on April 3, 2007. Effective January 1, 2006, the Company adopted the fair value recognition provisions of SFAS 123R using the modified prospective transition method.

Earnings per common share: Earnings per common share - basic represents income available to common stockholders divided by the weighted average number of common shares outstanding during the periods presented. The diluted earnings per common share amounts were computed using the weighted average number of common shares outstanding during the periods presented, adjusted for the effect of dilutive potential common shares equivalents, which consists of outstanding stock options and warrants.   The earnings per common share  diluted for all periods presented other than the quarter ended September 30, 2007 is the same as earnings per common share  basic because the effect of stock options and warrants is anti-dilutive in those periods.



For the quarter ended September 30, 2007, the weighted average common shares outstanding has been adjusted by 969,274 shares for the dilutive effect of outstanding stock options and 1,364,294 shares for the dilutive effect of outstanding warrants.



The calculations for the basic and diluted loss per share were based upon net income or loss attributable to common stockholders and a weighted average number of common shares outstanding for the periods ended September 30, 2007 and 2006.

Income taxes: Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for all the effects of changes in tax laws and rates on the date of enactment.

On January 1, 2007, the Company adopted Financial Accounting Standards Board (FASB) Interpretation (FIN) 48, Accounting for Uncertainty in Income Taxes. FIN 48, an interpretation of Statement of Financial Accounting Standard (SFAS) 109, Accounting for Income Taxes, clarifies the accounting and disclosure requirements for uncertainty in tax positions as defined by the standard. In connection with the adoption of FIN 48, the Company has analyzed its filing positions in all significant jurisdictions where it is required to file income tax returns for the open tax years in such jurisdictions. The Company has identified three states as major tax jurisdictions, as defined by FIN 48, its federal income tax return and its state income tax. The Company has not earned a profit and has recorded no asset or liability for taxes.  The Companys income tax returns in
major state income tax jurisdictions remain subject to examination for various periods subsequent to December 31, 2003. The Company currently believes that all significant filing positions are highly certain and that, more likely than not, all of its significant income tax filing positions and deductions would be sustained. Therefore, the Company has no significant reserves for uncertain tax positions and no adjustments to such reserves were required upon the adoption of FIN 48. If interest and penalties are assessed, interest costs will be recognized in interest expense and penalties will be recognized in operating expenses.

New accounting pronouncements: In February 2007, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 159,The Fair Value Option for Financial Assets and Financial Liabilities  Including an Amendment of FASB Statement No. 115, which provides all entities, including not-for-profit organizations, with an option to report selected financial assets and liabilities at fair value.  The objective of  Statement No. 159 is to improve financial reporting by providing entities with the opportunity to mitigate volatility in earnings caused by measuring related assets and liabilities differently without having to apply the complex provisions of hedge accounting.  Certain specified items are eligible for the irrevocable fair value measurement option as established by Statement No. 159.  Statement No. 159 is effective as of
the beginning of an entitys first fiscal year beginning after November 15, 2007.  Early adoption is permitted as of the beginning of a fiscal year that begins on or before November 15, 2007 provided the entity also elects



10



---



to apply the provisions of Statement No. 157,Fair Value Measurements.  The Company is currently evaluating the impact that the adoption of Statement No. 159 will have on its financial position, results of operation and cash flows.

Reclassification: Certain items in the Consolidated Statement of Operations for the three and nine month periods ended September 30, 2006 have been reclassified to be consistent with current presentation adopted by the Company.  These reclassifications had no effect on net loss or stockholders equity.

Note 2. Long-Term Debt

In December 2004, the Company opened a line of credit with Wells Fargo Bank, NA  The line of credit, as amended from time to time, allowed a maximum credit facility of $5,000,000 and had a maturity date of March 31, 2007.  The line of credit did not have a balance at any time during the quarter ended March 31, 2007.  The line of credit terminated on March 31, 2007.



Long-term debt consists of the following:



September 30,
2007
        
        December 31, 2006Note payable to Capital One Bank $135,000 due September 2009, due in monthly installments of approximately $ 4,143 including interest at 6.5%.
        
        89,252
        
        
        121,263Note payable to Patient Infosystems, Inc. due February 2007 bearing interest at 6%.  Inter-company payable to Patient Infosystems, Inc. was converted to note at time of distribution to stockholders.
        
        -
        
        
        300,505Capital lease obligations
        
        25,699
        
        
        32,491114,951
        
        
        454,259Less current maturities
        
        (55,041)
        
        
        (352,718)Long-term debt, less current maturities
        $
        59,910
        
        $
        101,541




Note 3. Stock Options and Warrants

The Company has a stock option plan (the Stock Option Plan) for the benefit of certain employees, non-employee directors, and key advisors. On May 16, 2005, the stockholders approved the Stock Option Plan, which (i) authorized 2,249,329 (split adjusted ) options and (ii) established the class of eligible participants to include employees, nominees to the Board of Directors of the Company, and consultants engaged by the Company, and limited to 50,000 the number of shares of Common Stock underlying the one-time grant of a Non-Qualified Option to which non-employee directors or non-employee nominees of the Board of Directors may be entitled. The Company filed a Form S-8 registering 2,249,329 of the Stock Option Plan shares on April 7, 2006. Stock options granted under the Stock Option Plan may be of two types: (1) incentive stock options and (2) nonqualified stock options. The option price of such
grants shall be determined by a Committee of the Board of Directors (the Committee), but shall not be less than the estimated fair market value of the common stock at the date the option is granted. The Committee shall fix the terms of the grants, with no option term lasting longer than ten years. The vesting schedules of such options shall be determined by the Committee when the options are granted.

On May 24, 2007, the Company amended the Stock Option Plan to increase the maximum number of shares of Common Stock that may be issued pursuant to the Stock Option Plan.  Accordingly, the American CareSource Holdings, Inc. Amended and Restated 2005 Stock Option Plan increased the shares available



11



---



for issue under the Stock Option Plan by 1,000,000 shares to a total of 3,249,329 shares.  The Company filed a Form S-8 registering the additional shares on June 14, 2007.

A summary of stock option activity follows:



Outstanding Options
        
        Weighted-Average Exercise PriceOptions outstanding at December 31, 2006
        1,848,192
        
        $
        0.90Q1 2007 ActivityOptions granted
        117,000
        
        $
        2.11Options forfeited by holders
        (65,312
        )
        $
        4.79Options exercised
        (6,183
        )
        $
        0.31Options outstanding
        1,893,697
        
        $
        0.91Q2 2007 ActivityOptions granted
        330,000
        
        $
        1.84Options forfeited by holders
        (348,258
        )
        $
        0.81Options exercised
        (1,500
        )
        $
        0.31Options outstanding
        1,873,939
        
        $
        1.03Q3 2007 ActivityOptions granted
        153,500
        
        $
        2.30Options forfeited by holders
        (7,151
        )
        $
        2.19Options exercised
        (159,869
        )
        $
        0.34Options outstanding
        1,860,419
        
        $
        1.20




On July 2, 2007, the Company announced that it had signed an Ancillary Care Services Network Access Agreement (the Ancillary Care Services Agreement) effective as of May 21, 2007 (the Effective Date) with a new customer, Texas True Choice, Inc. (Texas True Choice), a Texas-based preferred provider organization network, and certain subsidiaries of Texas True Choice.  As partial compensation to Texas True Choice under the Ancillary Care Services Agreement, the Company issued to Corporate Health Plans of America, Inc., an affiliate of Texas True Choice, warrants to purchase a total of 225,000 shares of the Companys common stock at an exercise price of $1.84, the closing price of the common stock of the Company as reported on the American Stock Exchange on the Effective Date.  These warrants vested as to 25% of the shares on the Effective Date, shall vest an additional 25%
on each anniversary date of the Effective Date, and have an expiration date of May 20, 2012.  In the event of an early termination of the Ancillary Care Services Agreement, the warrants terminate with respect to all unvested shares at the time of such early termination.



12



---



SPECIAL CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This discussion includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, as amended. You can identify these statements by forward-looking words such as may, will, expect, intend, anticipate, believe, estimate and continue or similar words. You should read statements that contain these words carefully because they discuss our future expectations, contain projections of our future operating results or of our financial condition or state other forward-looking information.

In an effort to give investors a well-rounded view of the Companys current condition and future opportunities, this quarterly report contains forecasts by the Companys management about the Companys future performance and results. Because they are forward-looking, these forecasts involve substantial risks and uncertainties. They include, but are not limited to, risks of market acceptance of, or preference for, the Companys systems and services, competitive forces, the impact of and changes in government regulations, general economic factors in the healthcare industry, and other risk factors as may be listed from time to time in the Companys filings with the SEC. In evaluating such forward-looking statements, investors should specifically consider the various factors identified in this quarterly report, including the matters set forth under the caption Risk
Factors beginning on page 20 of this quarterly report, those appearing in our annual report on Form 10-KSB for the year ended December 31, 2006, first filed with the SEC on April 2, 2007 and subsequently amended and filed with the SEC on April 3, 2007, as well as any other cautionary language in this filing, any of which could cause our actual results to differ materially from the expectations we describe in our forward-looking statements.  We disclaim any obligation to update information contained in any forward-looking statement.

Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations

This Managements Discussion and Analysis provides a review of the Companys operating results for the three and nine months ended September 30, 2007 and its financial condition at September 30, 2007. The focus of this review is on the underlying business reasons for significant changes and trends affecting the revenues, net losses and financial condition of the Company. This review should be read in conjunction with the accompanying consolidated financial statements and the consolidated financial statements and the notes thereto included in our annual report on Form 10-KSB for the year ended December 31, 2006.

Overview

The Company was incorporated in November 2003 as a wholly-owned subsidiary of Patient InfoSystems, Inc. (Patient Infosystems) to facilitate Patient Infosystems acquisition of the assets of American CareSource Corporation.  American CareSource Corporation was incorporated as Physicians Referral Network in 1995 and merged into Health Data Solutions, Inc. in October 1997. At the time of such merger, Health Data Solutions changed its name to American CareSource Corporation. American CareSource Corporation was acquired by Patient Infosystems on December 31, 2003. The business of the Company includes the previous business of American CareSource Corporation.  The Company became an independent company when Patient Infosystems distributed the shares of the Company to its shareholders on December 23, 2005.



The Company is in the business of delivering ancillary healthcare services through its national network of ancillary care providers. The Company operates from one leased facility in Dallas, Texas, which also contains its executive offices.  The Company currently has 40 full-time employees and no part-time employees.  The Company markets its products to insurance companies, third party administrators and preferred provider organizations.

The Company recognizes revenues for ancillary healthcare services when services by providers have been authorized and performed and collections from payors are reasonably assured. Cost of revenues for ancillary healthcare services consist of amounts due to providers for providing patient services, client administration fees paid to our client payors to reimburse them for the cost of implementing and managing claims submissions, and the Companys related direct labor and overhead of processing invoices, collections and payments. The Company is not liable for costs incurred by independent contract service



13



---



providers until payment is received by the Company from the payors. The Company recognizes actual or estimated liabilities to independent contract service providers as the related revenues are recognized.

The Company has never operated at a profit, and will require significant growth in either claims volume from existing contracts, new contracts, or both, in order to generate sufficient operational margin to become profitable. No assurances can be given that sufficient sources of new revenue will be identified and other sources of capital may have to be secured by the Company to support its operations. If the Company is unable to generate enough working capital either from its own operations or through the sale of its equity securities, it may be required to curtail or cease operations.

On July 12, 2007, Wayne A. Schellhammer resigned as a member of the Board of Directors and Chief Executive Officer of the Company.  On September 23, 2007, David S. Boone was promoted to President and Chief Executive Officer of the Company.  More recently, on October 25, 2007, Steven J. Armond joined the Company as Chief Financial Officer.

Results of Operations

The three months ended September 30, 2007 compared to the three months ended

September 30, 2006:



Statement of Operations for the Quarters EndedSeptember 30, 2007
        
        September 30, 2006Net Revenue
        $7,088,499
        
        $3,313,440Cost of revenue
        6,091,789
        
        2,689,471Net margin
        996,710
        
        623,969Selling, general and administrative expense
        766,648
        
        665,841Depreciation and amortization
        86,445
        
        77,271Operating Income (Loss)
        143,617
        
        (119,143)Financing (Income) Expense
        (44,594)
        
        (2,767)Net Income (Loss)
        $188,211
        
        ($116,376)




The Companys revenues are generated from ancillary healthcare service claims. Net revenues increased to $7,088,499 from $3,313,440 during the quarter ended September 30, 2007 as compared to the quarter ended September 30, 2006. This represents an increase of $3,775,059 or 114%.   Approximately $3.4 million of the increase was due to the addition of three new clients in 2007.  In addition, revenue from one established client increased approximately $1.0 million in the third quarter of 2007 compared to the same quarter in 2006 due to our expansion of services for that client.  Offsetting these increases, revenue from another one of our clients declined for the quarter compared to the same period in 2006 due to a previously disclosed effort by that client to contract directly with certain service providers.

The Company expects to see continuing growth in the number of client and payor relationships by focusing on providing in-network services for its payors and aggressively pursuing preferred provider organizations and third party administrators as its primary sales target. The Company believes that this strategy should increase the volume of claims the Company can adjudicate as well as the volume of patients it can direct through its network. No assurances can be given that the Company can expand its provider or payor relationships, nor that any such expansion will result in an improvement in the results of operations of the Company.



14



---



Costs and Expenses

Cost of revenue is comprised of payments to our providers, administration fees paid to our client payors for converting claims to electronic data interchange and routing them to both the Company for processing and to their payors for payment, and the fixed costs of our network development and claims administration organizations.  Total cost of revenue increased from $2,689,471 for the quarter ended September 30, 2006 to $6,091,789 for the quarter ended September 30, 2007.  This represents an increase of 127% over the prior years comparable quarter.  Payments to providers increased by 155% compared to the third quarter of 2006.  This increase reflects increased amounts paid to providers for their services as a result of our increased revenue, as well as the results of the Companys decision to increase our discount to our client payors to provide them more value while maintaining
our reimbursement rate to the service providers in our network.  Administration fees increased 189% over the prior years comparable period due to the addition of three new clients and an expanded relationship with an existing client.  Fixed costs decreased 1% compared with the prior years comparable period.

Net margin (net revenue less cost of revenue) for the quarter ended September 30, 2007 was $996,710 compared to $623,969 for the quarter ended September 30, 2006.  Net margin as a percentage of net revenue for the quarter was 14.1% compared to 18.8% for the comparable period in 2006.  The increase in net margin is attributable primarily to the increase in revenue, offset by a variety of factors, including more aggressive pricing by the Company, fluctuations in the mix of services provided by the Company, and increased administration fees payable to clients.  The Company anticipates that it will continue to have margins in the percentage range of the 2007 level rather than the level experienced in 2006.



Selling, general and administrative expense increased by 15% to $766,648 for the quarter ended September 30, 2007 as compared to $665,841 for the quarter ended September 30, 2006. These costs consist primarily of salaries and related benefits, travel costs, sales commissions, sales materials, other marketing related expenses, costs of corporate operations, finance and accounting, human resources and other general operating expenses of the Company. The increase is primarily related to increased stock option expense in the quarter ended September 30, 2007 compared to the comparable period in 2006, sales commission increases commensurate with our increase in sales, and the addition of a bonus accrual in the quarter ended September 30, 2007 for management performance in the quarter.

Amortization and depreciation expense increased to $86,445 in the quarter ended September 30, 2007 compared to $77,271 in the quarter ended September 30, 2006. These expenses include $53,395 of amortization of intangibles which consists of $21,379 in amortization of certain software development costs and $32,016 in amortization of the capitalized value of provider contracts that were acquired as part of the acquisition of American CareSource Corporations assets by Patient Infosystems. The on-going value of these acquired contracts is re-evaluated each quarter to test for any potential impairment to this asset. As of September 30, 2007, the Companys analysis of its goodwill and related intangibles did not indicate any impairment.

Financing (Income) Expense

Interest income was $47,430 for the quarter ended September 30, 2007 as compared to $57,421 for the quarter ended September 30, 2006, due to a lower cash balance.  Interest expense decreased to $2,836 in the quarter ended September 30, 2007 as compared to $8,174 for the quarter ended September 30, 2006, primarily as a result of retiring debt payable to Patient Infosystems in February 2007.  The Company has fully amortized the debt issuance costs related to its line of credit with Wells Fargo Bank, NA and, as a result, debt issuance costs for the quarter ended September 30, 2007 were $0 as compared to $46,300 for the quarter ended September 30, 2006.

Taxes

The Company did not record an income tax expense for the quarter ended September 30, 2007 due to the valuation allowance that has been previously recorded on all deferred tax assets which would be reduced for any tax resulting from the current quarters net income.  The Company had no tax benefit in the quarter ended September 30, 2006 because it recorded a full valuation for its tax assets in that period.  The Companys deferred tax assets consist primarily of the tax benefit associated with its net operating loss carry forwards.



15



---



Management of the Company has evaluated the available evidence about future taxable income and other possible sources of realization of deferred tax assets. The valuation allowance reduces deferred tax assets to zero, which represents managements best estimate of the amount of such deferred tax assets that more likely than not will be realized.

Net Income (Loss)

The Company reported a net income of $188,211 for the quarter ended September 30, 2007 as compared to a loss of ($116,376) for the quarter ended September 30, 2006. On a per share basis, the Company earned $0.01 per basic share for the quarter ended September 30, 2007 as compared to a loss of ($0.01) per share for the quarter ended September 30, 2006.



The nine months ended September 30, 2007 compared to the nine months ended September 30, 2006:



Statement of Operations for the Nine Months EndedSeptember 30, 2007
        
        September 30, 2006Net Revenue
        $13,363,356
        
        $8,607,762Cost of revenue
        11,671,724
        
        6,904,779Net margin
        1,691,632
        
        1,702,983Selling, general and administrative expense
        2,677,920
        
        2,038,718Depreciation and amortization
        248,160
        
        235,618Operating loss
        (1,234,448)
        
        (571,353)Financing (income) expense
        (95,477)
        
        69,229Net loss
        ($1,138,971)
        
        ($640,582)




Revenues of the Company are comprised of revenues from ancillary healthcare service claims. Net revenues increased to $13,363,356 from $8,607,762 during the nine months ended September 30, 2007 as compared to the nine months ended September 30, 2006, an increase of $4,755,594 or 55%.  Approximately $4.4 million of the increase was due to the addition of three new clients in 2007.  In addition, revenue from one established client increased approximately $2.4 million for the nine months ended September 30, 2007 compared to the same quarter in 2006 due to our expansion of services for that client.  Offsetting these increases, revenue from another of our clients declined for the nine months ended September 30, 2007 compared to the same period in 2006 due to a previously disclosed effort by that client to contract directly with certain service providers.

The Company expects to see continuing growth in the number of client and payor relationships by focusing on providing in-network services for its payors and aggressively pursuing preferred provider organizations and third party administrators as its primary sales target. The Company believes that this strategy should increase the volume of claims the Company can adjudicate as well as the volume of patients it can direct through its network. No assurances can be given that the Company can expand its provider or payor relationships, nor that any such expansion will result in an improvement in the results of operations of the Company.

Costs and Expenses

Cost of revenue is comprised of payments to our providers, administration fees paid to our clients payors for converting claims to electronic data interchange and routing them both to the Company for processing and to their payors for payment, and the fixed costs of our network development and claims



16



---



administration organizations.  Total cost of revenue increased to $11,671,724 in the nine months ended September 30, 2007 from $6,904,779 in the nine months ended September 30, 2006.  This represents an increase of 69% over the same period in the prior year.  Payments to providers increased by 89% for the nine months ended September 30, 2007 compared to the same period in 2006.  This increase reflects increased amounts paid to providers for their services as a result of our increased revenue, as well as the results of the Companys decision to increase our discount to our client payors to provide them more value while maintaining our reimbursement rate to the service providers in our network.  Administration fees during the nine months ended September 30, 2007 increased 91% compared to the same period in the prior year due to the addition of three new clients that were implemented in May and August 2007
as well as to increased revenue because of an expanded relationship with an existing client.  Fixed costs decreased 2% for the nine months ended September 30, 2007 compared to the same period in the prior year.

Net margin (net revenue less cost of revenue) for the nine months ended September 30, 2007 was $1,691,632 compared to $1,702,983 for the nine months ended September 30, 2006.  Net margin as a percentage of net revenue for the nine months ended September 30, 2007 was 12.7% compared to 19.8% for the comparable period in 2006.  The decline in net margin is attributable to a variety of factors, including more aggressive pricing by the Company, fluctuations in the mix of services provided by the Company, and increased administrative fees payable to clients.  The Company anticipates that it will continue to have margins in the percentage range of the 2007 level rather than those levels experienced in 2006, though increased revenue levels should provide favorable leverage over fixed costs in future periods.

Selling, general and administrative expense increased by $639,201 to $2,677,920 for the nine months ended September 30, 2007 as compared to $2,038,718 for the nine months ended September 30, 2006. This constitutes an increase of 31% over the comparable period in the prior year.  These costs consist primarily of salaries and related benefits, travel costs, sales commissions, sales materials, and other marketing related expenses, costs of corporate operations, finance and accounting, human resources and other general operating expenses of the Company. Included in the expense for the nine months ended September 30, 2007 is a one-time severance charge of $338,010 for our former CEO, Wayne Schellhammer, who resigned effective as of June 30, 2007. The increase in selling and administrative expenses is primarily related to the addition of a bonus accrual in 2007 and increased stock option
compensation expense for the nine months ended September 30, 2007 as compared to the same period in 2006.  In addition, the Company incurred costs for its first annual meeting held in May 2007 and increased salescommissions associated with our higher sales.

Amortization and depreciation expense increased by $12,543 to $248,160 in the nine months ended September 30, 2007 as compared to $235,618 in the nine months ended September 30, 2006. These expenses include $160,186 of amortization of intangibles which consist of $64,137 in amortization of certain software development costs and $96,049 in amortization of the capitalized value of provider contracts that were acquired as part of the acquisition of American CareSource Corporations assets by Patient Infosystems. The on-going value of these acquired contracts is re-evaluated each quarter to test for any potential impairment to this asset. As of September 30, 2007, the Companys analysis of its goodwill and related intangibles did not indicate any impairment.

Financing (Income) Expense

Interest income was $151,063 for the nine months ended September 30, 2007 as compared to $132,753 for the nine months ended September 30, 2006, due to the higher cash balance for the entire nine months as a result of the equity financing settled in February and March 2006.  Interest expense decreased to $9,286 in the nine months ended September 30, 2007 as compared to $63,082 for the nine months ended September 30, 2006.  Some of the funds from the 2006 equity financing were used to pay the full balance of the companys credit line with Wells Fargo Bank, NA resulting in significantly reduced interest expense after February 2006.  In addition, retirement of debt payable to Patient Infosystems in February 2007 further contributed to the decrease.  The Company has fully amortized the debt issuance costs related to its line of credit with Wells Fargo Bank, and as a result, debt issuance
costs for the nine months ended September 30, 2007 were $46,300 as compared to $138,900 for the nine months ended September 30, 2006.



17



---



Taxes

The Company had no tax benefit in the nine months ended September 30, 2007 or the nine months ended September 30, 2006 due, in part, to recording a full valuation allowance to reduce its deferred tax assets. The Companys deferred tax assets consist primarily of the tax benefit associated with its net operating loss carry forwards.

Management of the Company has evaluated the available evidence about future taxable income and other possible sources of realization of deferred tax assets. The valuation allowance reduces deferred tax assets to zero, which represents managements best estimate of the amount of such deferred tax assets that more likely than not will be realized.

Net Loss

The Company reported a net loss of $(1,138,971) for the nine months ended September 30, 2007 as compared to $(640,552) for the nine months ended September 30, 2006. On a per share basis, the Company lost ($0.08) per share for the nine months ended September 30, 2007 and ($0.05) per share for the nine months ended September 30, 2006.

Liquidity and Capital Resources

As of September 30, 2007, the Company had a working capital surplus of $3,601,426 as compared to a working capital surplus of $4,202,027 at December 31, 2006. From its inception to this quarter, the Company has not generated positive cash flow from operations and has relied on external sources for its operational, working capital and capital expenditures needs.

In March 2006, the Company completed a private placement of its common stock. The offering raised approximately $10.0 million at a price of $5.00 per share. In connection with such private placement, the Company relied upon the exemption from registration provided under Section 4(2) of the Securities Act and Rule 506 of Regulation D promulgated thereunder. The net proceeds from the transaction were approximately $9.1 million.  In addition, the Company granted the accredited investors registration rights pursuant to a registration right agreement, which required the Company to file a registration statement covering the resale of all shares included in the private placement, including those shares underlying the warrants issued to the placement agent for the private placement.  The registration statement registering those shares for resale was filed with the SEC on April 7, 2006 and
declared effective by the SEC on May 11, 2006.  A portion of the proceeds from the March 2006 private placement was used to re-pay the full balance of the Wells Fargo Bank, NA credit line. The outstanding principal retired by the Company was $3,650,000. The remainder of the proceeds are being used to fund working capital and other general corporate purposes.

The Company incurred losses of approximately $1,140,000 during the nine months ended September 30, 2007.  These losses were funded by the Companys available capital.  If the Company is unable to reduce its losses, it will continue to reduce its available capital and will be required to identify alternative sources of financing including indebtedness or selling equity.  Any such financing would likely be dilutive to current stockholders and could result in significant additional costs.

Inflation

Inflation did not have a significant impact on the Companys costs during the quarters and nine months ended September 30, 2007 and September 30, 2006. The Company continues to monitor the impact of inflation in order to minimize its effects through pricing strategies, productivity improvements and cost reductions.

Critical Accounting Policies

Critical accounting policies are those that require application of managements most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.



18



---



The Companys significant accounting policies are described in Note 1 to the financial statements included in this quarterly report. Not all of these significant accounting policies require management to make difficult, subjective or complex judgments or estimates. However, the following accounting policies are deemed to be critical by the Companys management.

Use of Estimates. In preparing the financial statements, the Company uses estimates in determining the economic useful lives and possible impairments of its assets, provisions for doubtful accounts, tax valuation allowances and various other recorded or disclosed amounts. Estimates require management to use its judgment. While the Company believes that its estimates for these matters are reasonable, if the actual amount is significantly different than the estimated amount, its assets, liabilities or results of operations may be overstated or understated.

Intangible Assets. The value of the Companys intangible assets was derived from the allocation of the purchase price from the December 31, 2003 acquisition of the assets of American CareSource Corporation by Patient Infosystems. The allocation of purchase price was based on an independent appraisal of the acquired assets. The amounts assigned to each asset are being amortized on a straight line basis over the expected life of the asset, 5 years for software and 15 years for the provider contracts. The provider contracts do not have a specified contract period. Our experience to date demonstrates attrition of less than 2% per year, implying a greater than twenty year life.  However, we believe that 15 years represents a more realistic estimate. Accordingly, the Company has elected to amortize the value of these contracts over 15 years. The on going
value of these acquired contracts are re-evaluated each quarter using the discounted cash flow method to test for any potential impairment to this asset that would result from either reduced cash flows or a shorter than anticipated useful life. The contracts are accounted for as a pool of contracts. There will be no additions to the capitalized amounts that were established at the time of the acquisition since the cost of adding additional service providers is considered an ongoing operating expense.

Impairment of Long-Lived Assets. The Company records impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted future cash flows estimated to be generated by those assets are less than the carrying amount of those assets. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future net cash flows expected to be generated by the asset. If the asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. If the actual value is significantly less than the estimated value, Company assets may be overstated.

Revenue recognition. The Company evaluates its service provider contracts using the indicators of EITF No. 99-19 Reporting Gross Revenue as a Principal vs. Net as an Agent (EITF 99-19) to determine whether the Company is acting as a principal or an agent in the fulfillment of services to be rendered.

Revenues are recorded gross when services by providers have been authorized and performed and collections from third party payors are reasonably assured. The Company acts as principal under EITF 99-19 when settling claims for service providers through their contracted service provider network for the following reasons:




        The Company negotiates a contract with the service provider and also negotiates contracts with payors.  Neither the service provider nor the payor can look through the Company and claim directly against the other party.  Both contracts with these parties are separate and each only enters into contracts with the Company.  Each party deals directly with the Company and does not deal with each other directly.





        The Company determines through negotiations which payor will be included or excluded in the network to be offered to the service provider, based on, among other things, price and access.




19



---




        The Company does not earn a fixed dollar amount per customer transaction regardless of the amount billed to customers or earn a stated percentage of the amount billed to its customers.





        The Company is responsible to the service provider for processing claims and managing the claims its adjustors process.





        The Company sets prices to be settled with payors and separately negotiates the prices to be settled with the service providers.





        The Company may realize a positive or negative margin represented by the difference between the negotiated fees received from payors and the negotiated amount paid to service providers.





        When claims are recorded gross, the payors payment to the Company is recorded as revenue and the Companys payment to the service provider is recorded as cost of revenue in the statement of operations.  The Company does, however, record revenue on a net basis when an agency relationship exists.  When the Company receives a fee for claims processing and there are no financial risks to the Company, then only the claims processing fee is recorded as revenue.





        The Company does not have responsibility for collecting co-payments to be made or co-insurance claims to be received.  Accordingly, co-payments or co-insurance claims collected are not recorded as either revenue or cost of sales.


Off-balance sheet arrangements

The Company does not have any material off-balance sheet arrangements at September 30, 2007 or September 30, 2006, or for the periods then ended.

Pending Accounting Pronouncements

In September 2006, the FASB issued SFAS 157, Fair Value Measurements. SFAS 157 establishes, among other items, a framework for fair value measurements in the financial statements by providing a single definition of fair value, provides guidance on the methods used to estimate fair value and increases disclosures about estimates of fair value. The effective date of SFAS 157 for the Company is January 1, 2008. The Company is evaluating the effect of the adoption of this standard.

In February 2007, the Financial Accounting Standards Board (FASB) issued FASB Statement 159,The Fair Value Option for Financial Assets and Financial Liabilities  Including an Amendment of FASB Statement 115, which provides all entities, including not-for-profit organizations, with an option to report selected financial assets and liabilities at fair value.  The objective of Statement 159 is to improve financial reporting by providing entities with the opportunity to mitigate volatility in earnings caused by measuring related assets and liabilities differently without having to apply the complex provisions of hedge accounting.  Certain specified items are eligible for the irrevocable fair value measurement option as established by Statement 159.  Statement 159 is effective as of the beginning of an entitys first fiscal year beginning
after November 15, 2007.  Early adoption is permitted as of the beginning of a fiscal year that begins on or before November 15, 2007 provided the entity also elects to apply the provisions of Statement 157,Fair Value Measurements.  The Company is currently evaluating the impact that the adoption of Statement 159 will have on its financial position, results of operation and cash flows.

RISK FACTORS

You should carefully consider each of the following risk factors and all of the other information in this interim report on Form 10-QSB in addition to the Risk Factors set forth in the Companys annual report on Form 10-KSB for the year ended December 31, 2006, which was filed with the SEC on April 2, 2007, and subsequently amended and filed with the SEC on April 3, 2007. The following risks relate principally to the Companys business. If any of the following risks actually occur, the business, financial condition or results of operations of the Company could be materially adversely affected. As a result, the market price of shares of the Companys common stock could decline significantly.



20



---



The Company has a history of losses, has never been profitable and will likely continue to lose money for the foreseeable future.

The Company has incurred net losses in each year since its inception in December 2003 and has an accumulated deficit of approximately $7.7 million as of September 30, 2007. The Company will require significant growth in either claims volume for existing contracts, new contracts or both in order to generate sufficient operational margin to become profitable. No assurances can be given that the Company will be able to generate additional revenues or ever operate profitably in the future. In addition, our gross margin fluctuates due to pricing and mix of services.  There can be no assurance that the Companys margins will maintain at current levels.  The Companys prospects must be considered in light of the numerous risks, expenses, delays and difficulties frequently encountered in an industry characterized by intense competition, as well as the risks inherent in the development of new programs and the
commercialization of new services particularly given the Companys failure to date to operate profitably.

The Company has faced working capital shortfalls and may need to identify additional sources of capital within 12 months to maintain its operations.

The Company has never earned profits and its losses are continuing. Based on the Companys current plans, and as a result of the March 2006 private placement, the Company believes that it has sufficient funds to meet its operating expenses and capital requirements through 2007. If the Company is unable to reach profitability within the year, it will need to raise additional funds to continue its operations following that period. No assurance can be given that the Company will be able to obtain financing, or successfully sell assets or stock, or, even if such transactions are possible, that they will be on terms reasonable to the Company or that such transactions will enable the Company to satisfy its cash requirements. If the Company does not obtain additional funds, it will likely be required to eliminate programs, delay development of its products, alter its business plans, or, in the extreme situation,
cease operations.

The Company has a limited number of customers, a few of which account for a substantial portion of its business.

The Companys five largest customers accounted for approximately 97% of its revenues during the nine month period ended September 30, 2007 as compared to 98% of its revenue from the five largest customers during the nine month period ended September 30, 2006. Significant declines in the level of use of the Companys services by one or more of these customers could have a material adverse effect on the Companys business and results of operations. Additionally, an adverse change in the financial condition of any of these customers, including an adverse change as a result of a change in governmental or private reimbursement programs, could have a material adverse effect on the Companys business.  In January 2007, MedPartners d/b/a Lutheran (Lutheran), which accounted for 21% of the Companys revenue during 2006, began to contract directly with certain providers, which has
significantly reduced the Companys claim volume.  The Company anticipates that it will receive minimal revenue from Lutheran in future periods.  No assurance can be given that the Company will not lose additional substantial customers in the future.

There are no guarantees that the Companys clients will continue to do business with the Company and honor their contracts.   The failure to retain such clients could have a material adverse effect on its business and results of operations.

Generally, the Company enters into contracts ranging from two to four years with its clients with automatic renewals upon expiration.  However, these contracts are cancelable if the Company does not perform.  The following table illustrates the percentage of business these clients represented in the third quarter of 2007 and the remaining years left on their respective contracts:



Less than one year:
        3%One year to two years:
        0%Two to three years:
        58%Greater than three years:
        39%






21



---



There can be no assurance that clients will maintain their agreements with the Company or that clients will renew their contracts upon expiration, or on terms favorable to, the Company. Consequently, the failure to retain such clients could have a material adverse effect on the Companys business and results of operations.

Future sales of the Companys common stock, or the perception that these sales may occur, could depress the price of the Companys common stock.

Sales of substantial amounts of the Companys common stock, or the perception in the public that such sales may occur, could cause the market price of the Companys common stock to decline. This could also impair the ability of the Company to raise additional capital through the sale of equity securities. As of November 12, 2007, the Company has 14,661,758 shares of common stock outstanding. At November 12, 2007, there are outstanding warrants to purchase 1,953,752 shares of common stock.  Also, as of November 12, 2007, options to purchase 2,028,390 shares of common stock of the Company have been granted and are outstanding under the American CareSource Holdings, Inc. Amended and Restated 2005 Stock Option Plan, and there remains options available for grant to purchase 930,442 shares of the Companys common stock under the Plan.  If all of the outstanding warrants are exercised and all options
available under the Companys Amended and Restated 2005 Stock Option Plan are issued and exercised, there will be approximately 19,574,342 shares of common stock of the Company outstanding. Accordingly, the Companys stockholders could experience significant dilution.

Some of our existing stockholders can exert control over us and may not make decisions that further the best interests of all stockholders.

As of November 12, 2007, our principal stockholders (i.e., greater than 5% stockholders), officers and directors together control beneficially approximately 50.9% of our outstanding common stock. As a result, these stockholders, if they act individually or together, are able to exert a significant degree of influence over our management and affairs and over matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. Furthermore, the interests of this concentration of ownership may not always coincide with our interests or the interests of other stockholders and, accordingly, these stockholders could cause us to enter into transactions or agreements which we would not otherwise consider. In addition, this concentration of ownership may delay or prevent a merger or acquisition resulting in a change in control of us and might affect the market
price of our common stock, even when such a change in control may be in the best interest of all stockholders of the Company.



Item 3. Controls and Procedures

Evaluation of Disclosure Controls and Procedures.Our management, with the participation of our Chief Executive Officer, Chief Financial Officer, and Principal Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2007. Based upon this evaluation, our Chief Executive Officer, Chief Financial Officer, and Principal Accounting Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective for the recording, processing, summarizing and reporting of the information that the Company is required to disclose in the reports it files under the Exchange Act, within the time periods specified in the Securities and Exchange Commissions rules and forms.

Changes in Internal Controls Over Financial Reporting. There were no significant changes in the Companys internal controls  over financial reporting or in other factors that could significantly affect these controls subsequent to the date of their evaluation during the quarter ended September 30, 2007, including any corrective actions with regard to significant deficiencies and material weaknesses.



22



---



PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

During the interim period ended September 30, 2007 and as of the date of this filing, there were no material developments with respect to the two trademark disputes last reported in the Companys interim report on Form 10-QSB for the period ended June 30, 2007, which was filed with the SEC on August 14, 2007.

Item 5. Other Information.

On November 12, 2007, the Company issued a press release announcing its results of operations for the quarter ended September 30, 2007.  A copy of the press release is attached hereto as Exhibit 99.1.

Item 6. Exhibits.

See Exhibit Index following this Quarterly Report on Form 10-QSB.



23



---



SIGNATURES



In accordance with the requirements of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



American CareSource Holdings, Inc.Date:
        November 13, 2007
        
        By:
        /s/ David S. BooneDavid S. Boone
President and Chief Executive OfficerDate:
        November 13, 2007
        
        By:
        /s/ Steven M. PhillipsSteven M. Phillips
Controller and Principal
Accounting Officer






24



---



Exhibit Index



Exhibit #
        Description of Exhibits10.1
        Employment Agreement dated as of October 12, 2007 between the Company and Steven J. Armond.31.1
        Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.31.2
        Certification of the Principal Accounting Officer and Controller pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.32.1
        Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.99.1
        Press release of the Company dated November 12, 2007.








25